Pharmaq SA
0.8 FTEThe score of Pharmaq shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +500 % Total assets +89 % Headcount (avg FTE) -11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaq's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
- Year ended 31 Dec 2023filed on 07 Jun 2024
- Year ended 31 Dec 2022filed on 17 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Pharmaq's financial analysis
- Solvency34.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaq
Pharmaq's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.480.106
- VAT number
- BE0479480106
- Peppol
- Registered · 0208:0479480106 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Jan 2003
- Registered office
- 7011 Mons
- Size
- Micro · 0.8 FTE
- Latest accounts
- 2025 · filed on 04 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmaq (SA) has been based in Mons since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 22,968 € and equity of 128,237 €; its revenue is not published. With 0.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 34.2%, below the median of its sector (41.5%).
Companies similar to Pharmaq
Companies in the same business, of comparable size and area, outside its group.
- Adriaens-Louis Retail sale of pharmaceutical products Mons · balance sheet 402,839 €
- Pharmacie Derasse Retail sale of pharmaceutical products La Louvière · balance sheet 387,571 €
- Apotheek Vrijbroek Retail sale of pharmaceutical products Mechelen · balance sheet 387,647 €
- Curapharma Retail sale of pharmaceutical products Zaventem · balance sheet 352,271 €
- Paracelsus Retail sale of pharmaceutical products Aalst · balance sheet 413,042 €
- I & CM Marbotin Retail sale of pharmaceutical products Schaerbeek · balance sheet 323,588 €
- Farma Booischot Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 558,918 €
- Pharmenform Retail sale of pharmaceutical products Koekelberg · balance sheet 567,837 €
Frequently asked questions about Pharmaq
What is the revenue of Pharmaq?
Pharmaq files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaq?
In Belgium, the VAT number is the company number prefixed with BE: BE0479480106 for Pharmaq, if the company is VAT-registered. Its company number (CBE) is 0479.480.106.
Where is the registered office of Pharmaq?
According to the CBE register, the registered office of Pharmaq is in 7011 Mons.
What is the equity of Pharmaq?
At the close of the 2025 financial year, the equity of Pharmaq amounts to 128,237 €, a solvency of 34.2% of total assets.
How many people work at Pharmaq?
0.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmaq?
The register lists 2 active mandates at Pharmaq. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaq
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →